Drug Trial Radar · NCT03381287
A Multiple Ascending Dose Study of HTD1801 in Adults With Hypercholesterolemia
Last checked: Nov 19, 2026Latest source record: Aug 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
50
Actual
Start
Apr 13, 2018
Primary completion
Dec 31, 2018
Study completion Dec 31, 2018
Sponsor
- Lead sponsor
- HighTide Therapeutics (Hong Kong) LimitedIndustry
- Sponsor type
- Industry
- First posted
- Dec 21, 2017
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind, placebo-controlled, multicenter, multiple ascending dose (MAD) study to evaluate the safety and tolerability, pharmacokinetic (PK), and pharmacodynamic (PD) profiles of HTD1801 in overweight to obese adults with hypercholesterolemia. There were 3 cohorts of dose levels as 500, 1000 and 2000 mg/day, with 16 subjects planned for each cohort randomized 3:1 to receive either HTD1801 or Placebo.
Conditions
- Hypercholesterolemia
Interventions
HTD1801 Tablets, 500 mgDrug
500 mg/day (250 mg BID)
HTD1801 Tablets, 1000 mgDrug
1000 mg/day (500 mg BID)
HTD1801 Tablets, 2000 mgDrug
2000 mg/day (1000 mg BID)
Placebo to match 500 mg HTD1801Drug
2 tablets/day (1 tablet BID)
Placebo to match 1000 mg HTD1801Drug
4 tablets/day (2 tablet BID)
Placebo to match 2000 mg HTD1801Drug
8 tablets/day (4 tablet BID)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Subjects With Treatment-Emergent Adverse Events (TEAEs)Time frame: 4 weeks
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Q-Pharm Pty Ltd.
Herston, Queensland, Australia
CMAX Clinical Research Pty Ltd
Adelaide, South Australia, Australia
Linear Clinical Research
Nedlands, Western Australia, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.